Nateglinide and Mitiglinide, but Not Sulfonylureas, Induce Insulin Secretion through a Mechanism Mediated by Calcium Release from Endoplasmic Reticulum
Authors:
- Masashi KatsuraMKMasashi Katsura
- Masafumi MatsudaMMMasafumi Matsuda
- Seitaro OhkumaSOSeitaro Ohkuma
- Kohei KakuKKKohei Kaku
- 1 July 2007
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 322 (1) , 1-7
Abstract
Nateglinide and mitiglinide (glinides) are characterized as rapid-onset and short-acting insulinotropic agents. Although both compounds do not have a sulfonylurea structure, it has been postulated that insulin secretion is preceded by their binding to Kir6.2/SUR1 complex, and a mechanism of insulin secretion of glinides has been accounted for by this pathway. However, we hypothesized the involvement of additional mechanisms of insulin secretion enhanced by glinides, and we analyzed the pattern of time course of insulin secretion from MIN6 cells with the existence of agents that have specific pharmacologic actions. Dose-dependent effects of tolbutamide, glibenclamide, nateglinide, and mitiglinide were observed. Insulin secretion induced by 3 μM tolbutamide and 1 nM glibenclamide was completely inhibited by 10 μM diazoxide and 3 μM verapamil, although the latter half-component of insulin secretion profile induced by 3 μM nateglinide or 30 nM mitiglinide remained with the existence of those agents. Glinides enhanced insulin secretion even in Ca2+-depleted medium, and its pattern of secretion was same as the pattern with existence of verapamil. The latter half was suppressed by 1 μM dantrolene, and concomitant addition of verapamil and dantrolene completely suppressed the entire pattern of insulin secretion enhanced by nateglinide. Thus, we conclude that glinide action is demonstrated through two pathways, dependently and independently, from the pathway through KATP channels. We also demonstrated that the latter pathway involves the intracellular calcium release from endoplasmic reticulum via ryanodine receptor activation.Keywords
This publication has 30 references indexed in Scilit:
- Ryanodine receptors in human pancreatic β cells: localization and effects on insulin secretionThe FASEB Journal, 2004
- Pharmacological Agents That Directly Modulate Insulin SecretionPharmacological Reviews, 2003
- The Ryanodine Receptor Calcium Channel of β-CellsDiabetes, 2002
- Importance of Early Insulin SecretionDiabetes Care, 2001
- Glucose Tolerance and Cardiovascular MortalityArchives of internal medicine (1960), 2001
- Dysregulation of Insulin Secretion in Children With Congenital Hyperinsulinism due to Sulfonylurea Receptor MutationsDiabetes, 2001
- Glucose‐dependent and Glucose‐sensitizing Insulinotropic Effect of Nateglinide: Comparisonto Sulfonylureas and RepaglinideJournal of Diabetes Research, 2001
- Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (−)‐N‐(trans‐4‐isopropylcyclohexane‐carbonyl)‐d‐phenylalanine (A‐4166)British Journal of Pharmacology, 1997
- Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding proteinCell, 1994
- Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal isletsDiabetologia, 1993